Načítá se...
Neoadjuvant and adjuvant therapy for gastrointestinal stromal tumors
Gastrointestinal stromal tumors (GIST) are rare and mesenchymal in origin with a yearly incidence of 10‐15 cases per million people. If it is technically resectable, surgical resection is the mainstay of therapy regardless of tumor location,. Although complete (R0) resection can be achieved in up to...
Uloženo v:
| Vydáno v: | Ann Gastroenterol Surg |
|---|---|
| Hlavní autoři: | , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6345649/ https://ncbi.nlm.nih.gov/pubmed/30697609 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ags3.12211 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|